Addpharma is a company capable of developing top class IMDs (Incrementally Modified Drugs).
Several highly skilled personnel with previous experience in IMD drug development established the company in 2017.
We focus on development of IMDs and new drugs based on our expertise in FDCs (Fixed Dose Combinations),
controlled release formulations, and bioavailability enhancement drugs.

Our goal is not only expanding our business to the global market and becoming a competitive pharmaceutical company, but also strengthening the fundamentals of Korea’s pharmaceutical industry